Organoidsciences Ltd. (KOSDAQ:476040)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,750.00
+150.00 (1.74%)
At close: Aug 11, 2026

Organoidsciences Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
2,2952,4071,9531,591438.24
Revenue Growth
11.32%23.21%22.77%263.05%-
Gross Profit
2,2432,3581,9101,547411.98
Operating Income
-16,692-16,200-12,235-9,795-10,553
Net Income
-16,138-15,368-11,246-38,687-24,111
Earnings Per Share
-2507.42-2516.68-2691.00-13499.65-8413.46
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
12,00818,61616,19922,29830,429
Total Debt
7,4227,0548,0924,8864,325
Net Cash (Debt)
4,58611,5628,10717,41226,104
Net Cash Growth
-43.44%42.61%-53.44%-33.30%-
Net Cash Per Share
712.491893.371939.836075.699108.91

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-14,764-13,989-9,141-7,248-8,518
Capital Expenditures
-3,689-1,923-667.07-947.83-1,787
Free Cash Flow
-18,453-15,912-9,808-8,196-10,304
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
97.69%97.98%97.81%97.20%94.01%
Operating Margin
-727.15%-673.16%-626.38%-615.62%-2407.94%
Pretax Margin
-714.77%-654.00%-590.57%-2442.93%-5501.84%
Profit Margin
-703.01%-638.59%-575.78%-2431.56%-5501.84%
FCF Margin
-803.86%-661.20%-502.11%-515.13%-2351.33%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
25.10104.72---